Why China is a Genetic Powerhouse with a Problem
By Carolyn Abraham and Carolynne Wheeler,
The Globe and Mail
| 12. 15. 2012
[Quotes CGS's Marcy Darnovsky]
In the South China city of Shenzhen, a thriving manufacturing hub known for cheap goods and high-tech electronics, the genetic secrets of life roll off machines by the minute.Here at the global headquarters of BGI-Shenzhen, housed in a former shoe factory, the genomic revolution runs on an industrial scale. Powered by an army of young lab technicians and banks of high-end, U.S.-made sequencers that hum 24/7, the DNA of human kind is decoded with conveyor-belt speed and brute force.
But not just human DNA. Once known as the Beijing Genomics Institute, BGI is on a mission to sequence the genomes of a vast array of living things. It has already done rice, the cucumber, the Giant Panda, the Arabian camel, the chicken, the coronavirus behind severe acute respiratory syndrome (SARS), 40 strains of silkworm and the Tibetan antelope, to name just a few.
Its services are in high demand. It has unravelled the DNA of a 4,000-year-old Greenlander dubbed Inuk, teamed with Saudi Biosciences to sequence Arab genomes and with the University of Edinburgh to decode plants, animals and people...
Related Articles
By Nick Paul Taylor, BioSpace | 03.14.2024
A U.K. watchdog balked at the cost-effectiveness of Vertex Pharmaceuticals’ CRISPR-based sickle cell disease therapy Thursday, recommending against funding the treatment unless uncertainties can be cleared up satisfactorily.
The U.K. became the first country to authorize Vertex’s Casgevy (exagamglogene...
By Anna Collinson, Maryam Ahmed and Bella McShane, BBC | 03.12.2024
Women who freeze their eggs are being misled by some UK clinics about their chances of having a baby, a fertility charity says.
The Fertility Network was reacting to BBC analysis that found 41% of clinics offering the service privately...
By Isabelle Bartram, Guest Contributor
| 03.13.2024
Note: This article was originally published in February 2024 in issue 268 of the German-language journal Der Gen-ethische Informationsdienst (GID). It is also part of an English-language dossier on Heritable Human Genome Editing published at the same time. Minor edits have been made.
Calls for German embryo research
Pressure on the German Embryo Protection Act is growing. The scientific community is launching a renewed attack on the controversial law and demands access to embryos for so-called high-ranking research objectives. "Germline therapies" are...
By Andrew Joseph, STAT | 02.22.2024
In the years leading up to Russia’s invasion, Ukraine had become a burgeoning hub of clinical trials, particularly in oncology. The war put a hold on the vast majority of those studies.
But as the country marks two years this...